Hereditary Testing Market, Report Disease Type (Cystic Fibrosis, Sickle Cell Disease, and Hemophilia), By Technology, End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4703
|
Published Date
February 2026
|
Pages
280
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Hereditary Testing Market size was valued at US$16,110.20 Million in 2024, expanding at a CAGR of 14.01% from 2025 to 2032.
The United States holds a dominant position in the hematocrit testing market, driven by high utilization of blood tests, robust reimbursement policies, and the presence of leading diagnostic equipment manufacturers, supporting a wellintegrated healthcare system focused on timely diagnosis and patient management. In Europe, countries such as Germany, the UK, and France significantly influence the market through established laboratory networks and proactive preventive healthcare programs that encourage routine blood testing. Meanwhile, China and India are rapidly emerging as highgrowth markets, fueled by large patient populations, increasing awareness of diagnostic services, and the expansion of hospital and laboratory infrastructure that improves access to hematocrit testing.
Globally, genetic and congenital disorders — which often necessitate ongoing blood monitoring and related diagnostics — affect an estimated 6% of all births each year, with roughly 7.9million infants born with a genetic or partially genetic condition annually, according to World Health Organization data. This statistic underscores the importance of comprehensive testing, including hematocrit analysis, in supporting effective disease management and improving health outcomes worldwide. As a result, these regions are experiencing rising demand for diagnostic solutions that facilitate effective anemia management and overall health monitoring, reshaping the global hematocrit testing landscape.
Hereditary Testing Market- Market Dynamics
Increasing Prevalence of Genetic Disorders
The increasing prevalence of hereditary conditions such as cystic fibrosis, sickle cell disease, and various inherited cancers is a major driver of the hereditary testing market, as regular genetic screening and monitoring are critical for effective disease management, risk assessment, and patient counseling. Advancements in multi-gene panel testing have significantly enhanced diagnostic accuracy, efficiency, and clinical relevance, supporting wider adoption in routine clinical care.
Growing awareness among healthcare professionals and patients regarding the role of genetic testing in personalized medicine is further accelerating demand. For example, in November 2024, CeGaT GmbH launched the enhanced ExomeXtra v6 exome enrichment product, providing expanded coverage of non-coding splice regions and copy number variations (CNVs) to enable more precise diagnostics for hereditary conditions, including tumor syndromes. Additionally, ongoing innovations in laboratory automation, digital health platforms, and telemedicine are improving accessibility and turnaround times, reinforcing sustained market growth and technological advancement in the hereditary testing sector.
Hereditary Testing Market- Segmentation Analysis:
The Global Hereditary Testing Market is segmented based on Disease Type, Technology, End User, and Region.
Based on disease type, the market is segmented into cystic fibrosis, sickle cell disease, hemophilia, and other genetic disorders. Among these, cystic fibrosis and sickle cell disease testing account for significant shares due to the high prevalence of these inherited conditions and the increasing demand for early diagnosis and effective disease management. The growth is further supported by government-led newborn and population screening programs; for example, national screening initiatives in the U.S., the U.K., and several European countries mandate early detection of cystic fibrosis and sickle cell disease, ensuring timely intervention. Public health reports indicate that over 4 million newborns worldwide undergo screening for genetic disorders each year, highlighting the critical role of early intervention strategies in improving clinical outcomes and driving testing adoption.
Based on technology, the market is categorized into next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, and others. Next-generation sequencing dominates the segment due to its ability to deliver high accuracy, efficiency, and comprehensive gene panel analysis. NGS enables simultaneous testing of multiple genes, reducing both turnaround time and cost per test, making it particularly valuable in diagnosing complex genetic disorders. Government-backed genomics initiatives, such as the U.S. All of Us Research Program and the European Union’s 1+Million Genomes Project, have accelerated NGS adoption by funding infrastructure, research, and clinical implementation, with reports noting that NGS-based testing has grown by over 25% annually in publicly funded programs. These efforts also expand clinical applications across rare diseases, oncology, and personalized medicine.
By end user, the market is segmented into hospitals, diagnostic laboratories, genetic testing centers, and others. Hospitals and diagnostic laboratories hold the largest share due to their capacity to manage high testing volumes and provide integrated patient care through multidisciplinary teams. Advanced diagnostic infrastructure, including fully equipped molecular laboratories, enhances their ability to deliver comprehensive genetic testing and ongoing disease monitoring. Governments worldwide are increasingly supporting hospital-based genetic services to improve access and quality of care; for instance, national health systems report that over 60% of genetic testing for inherited disorders is conducted within hospital or large laboratory networks, underscoring their central role in the diagnosis, treatment, and management of genetic diseases.
Hereditary Testing Market- Geographical Insights
North America currently leads the hereditary testing market, driven by advanced healthcare infrastructure, high adoption of genetic testing, ongoing research initiatives, and favorable reimbursement policies. Europe follows closely, supported by wellestablished public health systems and increasing awareness of genetic disorders. The AsiaPacific region is expected to experience the fastest growth, fueled by rising healthcare expenditures, growing public awareness, and advancements in genetic testing technologies. Meanwhile, countries in Latin America and the Middle East & Africa are demonstrating steady growth, supported by gradual improvements in healthcare access and increasing demand for genetic testing services. Globally, genetic and congenital disorders remain a significant public health challenge — it is estimated that around 7.9million births (about 6% of total births) occur each year with a genetic or partially genetic defect, according to World Health Organization data — underscoring the widespread need for hereditary testing to support early diagnosis and disease management.
Hereditary Testing Market- Country Insights
The United States holds a dominant position in the hereditary testing market, driven by high testing volumes, advanced diagnostics, and the presence of leading genetic testing companies. In Europe, countries such as Germany, the UK, and France significantly contribute to market growth, supported by wellestablished healthcare systems that encourage routine genetic testing. In Asia, China and India are rapidly emerging as highgrowth markets, fueled by large populations, rising awareness of genetic health issues, and expanding healthcare infrastructure, which is improving access to hereditary testing solutions and driving overall demand. Globally, hereditary and congenital disorders remain a major public health concern — an estimated 7.9million children (about 6% of total births annually worldwide) are born with a genetic or partially genetic defect each year, according to the World Health Organization — underscoring the widespread need for genetic diagnostics and screening services to support early diagnosis and disease management.
Hereditary Testing Market- Competitive Landscape:
The hereditary testing market is moderately competitive, with key players including Illumina, Thermo Fisher Scientific, Quest Diagnostics, Invitae Corporation, Agilent Technologies, Myriad Genetics, GeneDx, Fulgent Genetics, ArcherDX, and BGI Group. These companies are focused on assay innovation, automation, and expanding test portfolios to meet the growing demand for genetic diagnostics. Significant investments in next-generation sequencing (NGS) technologies, streamlined workflows, and integrated solutions are enhancing both accuracy and operational efficiency.
Strategic partnerships and geographic expansion remain critical strategies for strengthening market positions in response to increasing demand for hereditary testing services. For example, in February 2025, Fulgent Genetics partnered with Foundation Medicine to introduce two hereditary germline tests — FoundationOne Germline and FoundationOne Germline More — in the U.S., leveraging Fulgent’s advanced technology platform to expand comprehensive genetic testing capabilities.
Recent Developments:
-
In November 2024, CeGaT GmbH launched version 6 (v6) of its proprietary ExomeXtra exome enrichment product, enhancing coverage of non-coding splice regions and copy number variations (CNVs). This upgrade improves diagnostic accuracy for hereditary tumor syndromes by enabling the detection of a broader spectrum of genetic alterations, including rare and complex variants that were previously difficult to identify.
-
In October 2023, a rural hospital system in North Carolina, in collaboration with Invitae, implemented universal hereditary testing for all breast cancer patients. The initiative achieved a 91.4% testing uptake and identified pathogenic germline variants in 13% of tested patients, resulting in changes to clinical management in nearly 70% of cases. This program demonstrates the effectiveness of integrating hereditary testing into diverse healthcare settings, improving patient outcomes while optimizing healthcare resource utilization.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEREDITARY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina
- Thermo Fisher Scientific
- Quest Diagnostics
- Invitae Corporation
- Agilent Technologies
- Myriad Genetics
- GeneDx
- Fulgent Genetics
- Archerdx
- BGI Group
- Others
GLOBAL HEREDITARY TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Cystic Fibrosis
- Sickle Cell Disease
- Hemophilia
- Others
GLOBAL HEREDITARY TESTING MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Others
GLOBAL HEREDITARY TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Genetic Testing Centers
- Others
GLOBAL HEREDITARY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Hereditary Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Hereditary Testing Market Snippet by Disease Type
2.1.2. Hereditary Testing Market Snippet by Technology
2.1.3. Hereditary Testing Market Snippet by End User
2.1.4. Hereditary Testing Market Snippet by Country
2.1.5. Hereditary Testing Market Snippet by Region
2.2. Competitive Insights
3. Hereditary Testing Key Market Trends
3.1. Hereditary Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hereditary Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hereditary Testing Market Opportunities
3.4. Hereditary Testing Market Future Trends
4. Hereditary Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hereditary Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Hereditary Testing Market Landscape
6.1. Hereditary Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hereditary Testing Market – By Disease Type
7.1. Overview
7.1.1. Segment Share Analysis, By Disease Type, 2024&2032 (%)
7.1.2. Cystic Fibrosis
7.1.3. Sickle Cell Disease
7.1.4. Hemophilia
7.1.5. Others
8. Hereditary Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
8.1.2. Next-Generation Sequencing (NGS)
8.1.3. Polymerase Chain Reaction (PCR)
8.1.4. Microarray
8.1.5. Others
9. Hereditary Testing Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Laboratories
9.1.4. Genetic Testing Centers
9.1.5. Others
10. Hereditary Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Hereditary Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3. Europe
10.3.1. Overview
10.3.2. Hereditary Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.8.3. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.8.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.9.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.9.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.10.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.10.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.11.3. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.11.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.12.3. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.12.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.14.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.14.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.15.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.15.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Hereditary Testing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.4.4. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.7.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.7.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.8.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.12.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.12.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.13.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.14.3. PhilippinesMarket Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Hereditary Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.5.4. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Hereditary Testing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
10.6.4. MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.8.3. UAE Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.8.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Billion)
10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
11. Key Vendor Analysis- Hereditary Testing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Illumina
11.2.2. Thermo Fisher Scientific
11.2.3. Quest Diagnostics
11.2.4. Invitae Corporation
11.2.5. Agilent Technologies
11.2.6. Myriad Genetics
11.2.7. GeneDx
11.2.8. Fulgent Genetics
11.2.9. Archerdx
11.2.10. BGI Group
11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEREDITARY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina
- Thermo Fisher Scientific
- Quest Diagnostics
- Invitae Corporation
- Agilent Technologies
- Myriad Genetics
- GeneDx
- Fulgent Genetics
- Archerdx
- BGI Group
- Others
GLOBAL HEREDITARY TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Cystic Fibrosis
- Sickle Cell Disease
- Hemophilia
- Others
GLOBAL HEREDITARY TESTING MARKET, BY TECHNOLOGY ANALYSIS, 2019 - 2032
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Others
GLOBAL HEREDITARY TESTING MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Genetic Testing Centers
- Others
GLOBAL HEREDITARY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
